Incyte to Present at Upcoming Investor Conference

WILMINGTON, Del.--(BUSINESS WIRE)-- Incyte (Nasdaq: INCY) announced today that it will present at the 2022 RBC Capital Markets Healthcare Conference on Tuesday, May 17, 2022 at 10:30 a.m. ET in New York.

The presentation will be webcast live and can be accessed at Investor.Incyte.com and will be available for replay for 30 days.

About Incyte
Incyte is a Wilmington, Delaware-based, global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visit Incyte.com and follow @Incyte.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220504005006/en/

Media
Catalina Loveman
+1 302 498 6171
[email protected]

Investors
Christine Chiou
+1 302 274 4773
[email protected]

Source: Incyte

You May Also Be Interested In

• SkyDrive signs MoU on eVTOL Operations in Japan with Japan Biz Aviation, Operator of HondaJet and Bell Helicopter Charters
• Futu Holdings Limited Securities Fraud Class Action Result of Undisclosed Regulatory Compliance Failures and approximately 32% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Fo
• "Search, Not Discounts, Decided Amazon Prime Day 2026's Beauty Winners: Market Defense Report"